Sonnet BioTherapeutics Holdings, Inc.
SONN
$3.47
$0.092.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.78M | -3.49M | -3.16M | -3.13M | -3.51M |
| Total Depreciation and Amortization | 22.20K | 22.10K | 22.20K | 21.60K | 21.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 138.30K | 487.30K | 72.40K | 60.40K | 432.60K |
| Change in Net Operating Assets | 1.86M | 510.40K | 155.90K | -123.60K | -17.60K |
| Cash from Operations | -1.76M | -2.47M | -2.91M | -3.17M | -3.07M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -12.00K | -- | 0.00 | -12.00K |
| Cash from Investing | 0.00 | -12.00K | -- | 0.00 | -12.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 41.10K | 51.20K | 7.71M | -- | 3.01M |
| Repurchase of Common Stock | -- | -- | -- | -21.80K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.00K | -370.20K | -88.90K | -212.90K | -157.50K |
| Cash from Financing | 21.10K | -319.00K | 7.62M | -234.70K | 2.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.74M | -2.80M | 4.71M | -3.40M | -231.90K |